| 股號 / 名稱 | 營收 | 稅後淨利 |
| ABBV 艾伯維 | 14,301,000,000.0 | 824,000,000.0 |
| AZN AstraZeneca PLC | 12,024,000,000.0 | 959,000,000.0 |
| BMY 施貴寶 | 11,477,000,000.0 | 1,762,000,000.0 |
| AMGN 美國安進 | 8,196,000,000.0 | 767,000,000.0 |
| GILD 吉利德科學 | 7,114,000,000.0 | 1,416,000,000.0 |
| REGN 雷傑納榮製藥 | 3,434,300,000.0 | 1,159,600,000.0 |
| MRNA 莫德納 | 2,811,000,000.0 | 217,000,000.0 |
| VRTX 福泰製藥 | 2,517,700,000.0 | 968,800,000.0 |
| BIIB Biogen Inc | 2,386,300,000.0 | 248,900,000.0 |
| ILMN Illumina Inc | 1,122,000,000.0 | -175,000,000.0 |
| INCY 英賽德 | 1,013,341,000.0 | 201,079,000.0 |
| ARGX argenx SE | 736,626,000.0 | -171,814,000.0 |
| BIO.B Bio Rad Laboratories Inc | 681,184,000.0 | 349,708,000.0 |
| BMRN Biomarin Pharmaceutical Inc | 648,833,000.0 | 88,662,000.0 |
| EXAS Exact Sciences Corp | 646,885,000.0 | -49,766,000.0 |
| BGNE Beigene Ltd | 634,409,000.0 | -367,553,000.0 |
| QGEN Qiagen NV | 509,162,000.0 | 97,664,000.0 |
| EXEL Exelixis Inc | 479,652,000.0 | 85,518,000.0 |
| ALNY Alnylam Pharmaceuticals Inc | 439,718,000.0 | -137,870,000.0 |
| SRPT Sarepta Therapeutics Inc | 396,781,000.0 | 45,655,000.0 |
| ALKS Alkermes Plc | 377,475,000.0 | 276,179,000.0 |
| BEAM Beam Therapeutics Inc | 316,192,000.0 | 142,797,000.0 |
| HCM HUTCHMED (China) Ltd | 305,125,000.0 | -68,374,000.0 |
| NVAX Novavax Inc | 291,342,000.0 | -178,389,000.0 |
| EBS Emergent BioSolutions Inc | 276,600,000.0 | -49,500,000.0 |
| TECH Bio-Techne Corp | 272,598,000.0 | 27,465,000.0 |
| ACAD ACADIA Pharmaceuticals Inc | 231,041,000.0 | 45,797,000.0 |
| HALO Halozyme Therapeutics Inc | 230,039,000.0 | 85,388,000.0 |
| CRSP CRISPR Therapeutics AG | 201,206,000.0 | 89,347,000.0 |
| MYGN Myriad Genetics Inc | 196,600,000.0 | -31,200,000.0 |
| HRMY Harmony Biosciences Holdings Inc | 168,412,000.0 | 26,607,000.0 |
| RGEN Repligen Corp | 155,743,000.0 | -25,488,000.0 |
| NEO Neogenomics Inc | 155,552,000.0 | -14,326,000.0 |
| GH Guardant Health Inc | 155,054,000.0 | -187,043,000.0 |
| APLS Apellis Pharmaceuticals Inc | 146,377,000.0 | -88,576,000.0 |
| ITCI Intra-Cellular Therapies Inc | 132,099,000.0 | -28,579,000.0 |
| ANIP ANI Pharmaceuticals Inc | 131,654,000.0 | 1,155,000.0 |
| RARE Ultragenyx Pharmaceutical Inc | 127,392,000.0 | -123,190,000.0 |
| FOLD Amicus Therapeutics Inc | 115,082,000.0 | -33,843,000.0 |
| STRO Sutro Biopharma Inc | 113,721,000.0 | 31,065,000.0 |
| CHRS Coherus BioSciences Inc | 91,524,000.0 | -79,653,000.0 |
| VYGR Voyager Therapeutics Inc | 90,061,000.0 | 56,395,000.0 |
| CERT Certara Inc | 88,010,000.0 | -12,456,000.0 |
| MDXG MiMedx Group Inc | 86,832,000.0 | 62,688,000.0 |
| AGEN Agenus Inc | 83,801,000.0 | -48,582,000.0 |
| INSM Insmed Inc | 83,693,000.0 | -186,061,000.0 |
| KNSA Kiniksa Pharmaceuticals Ltd | 79,858,000.0 | -17,704,000.0 |
| LEGN Legend Biotech Corp | 79,464,000.0 | -144,818,000.0 |
| AMRN Amarin Corporation PLC | 74,713,000.0 | -5,781,000.0 |
| MRVI Maravai LifeSciences Holdings Inc | 74,141,000.0 | -109,982,000.0 |
| ADMA ADMA Biologics Inc | 73,903,680.0 | -17,644,530.0 |
| SPRO Spero Therapeutics Inc | 73,522,000.0 | 51,191,000.0 |
| PBYI Puma Biotechnology Inc | 72,178,000.0 | 12,268,000.0 |
| BPMC Blueprint Medicines Corp | 71,957,000.0 | -110,916,000.0 |
| AXSM Axsome Therapeutics Inc | 71,530,000.0 | -98,651,000.0 |
| TWST Twist Bioscience Corp | 71,498,000.0 | -43,008,000.0 |
| RVNC Revance Therapeutics Inc | 69,799,000.0 | -55,699,000.0 |
| MIRM Mirum Pharmaceuticals Inc | 69,554,000.0 | -35,659,000.0 |
| CSTL Castle Biosciences Inc | 66,120,000.0 | -2,580,000.0 |
| ZLAB Zai Lab Ltd | 65,830,000.0 | -95,429,000.0 |
| VCEL Vericel Corp | 64,996,000.0 | 12,993,000.0 |
| ACLX Arcellx Inc | 63,148,000.0 | 19,844,000.0 |
| SANG Sangoma Technologies Corp | 62,276,000.0 | -3,239,000.0 |
| EDIT Editas Medicine Inc | 60,049,000.0 | -18,874,000.0 |
| PTGX Protagonist Therapeutics Inc | 60,000,000.0 | 27,335,000.0 |
| MNKD MannKind Corp | 58,472,000.0 | 1,401,000.0 |
| CTKB Cytek Biosciences Inc | 58,233,000.0 | 5,503,000.0 |
| DVAX Dynavax Technologies Corp | 55,596,000.0 | 219,000.0 |
| DCPH Deciphera Pharmaceuticals Inc | 48,294,000.0 | -47,190,000.0 |
| KYMR Kymera Therapeutics Inc | 47,885,000.0 | -14,368,000.0 |
| ADPT Adaptive Biotechnologies Corp | 45,784,000.0 | -69,467,000.0 |
| VNDA Vanda Pharmaceuticals Inc | 45,271,000.0 | -2,400,000.0 |
| TVTX Travere Therapeutics Inc | 45,059,000.0 | -88,596,000.0 |
| ME 23andMe Holding Co. | 44,747,000.0 | -277,976,000.0 |
| TGTX TG Therapeutics Inc | 43,971,000.0 | -14,416,000.0 |
| ANIK Anika Therapeutics Inc | 42,971,000.0 | -63,000,000.0 |
| KRYS Krystal Biotech Inc | 42,143,000.0 | 8,692,000.0 |
| TRDA Entrada Therapeutics Inc | 41,848,000.0 | -9,544,000.0 |
| ROIV Roivant Sciences Ltd | 37,140,000.0 | 5,072,665,000.0 |
| KMDA Kamada Ltd | 36,432,000.0 | 5,058,000.0 |
| DNA Ginkgo Bioworks Holdings Inc | 34,755,000.0 | -211,694,000.0 |
| RCUS Arcus Biosciences Inc | 31,000,000.0 | -81,000,000.0 |
| ARCT Arcturus Therapeutics Holdings Inc | 30,855,000.0 | -11,707,000.0 |
| WVE WAVE Life Sciences Ltd | 29,056,000.0 | -16,256,000.0 |
| LGND Ligand Pharmaceuticals Inc | 28,101,000.0 | 18,188,000.0 |
| CTMX CytomX Therapeutics Inc | 26,607,000.0 | 837,000.0 |
| CDXS Codexis Inc | 26,561,000.0 | -7,192,000.0 |
| AKYA Akoya Biosciences Inc | 26,487,000.0 | -10,802,000.0 |
| ALIM Alimera Sciences Inc | 26,306,000.0 | -3,781,000.0 |
| CDMO Avid Bioservices Inc | 25,395,000.0 | -9,509,000.0 |
| PSTX Poseida Therapeutics Inc | 24,995,000.0 | -25,349,000.0 |
| RYTM Rhythm Pharmaceuticals Inc | 24,234,000.0 | -41,633,000.0 |
| URGN Urogen Pharma Ltd | 23,530,000.0 | -26,016,000.0 |
| YMAB Y-mAbs Therapeutics Inc | 23,363,000.0 | -988,000.0 |
| AYTU Aytu Biopharma Inc | 22,934,000.0 | -220,000.0 |
| RGNX Regenxbio Inc | 22,213,000.0 | -62,889,000.0 |
| CDXC Chromadex Corp | 21,196,000.0 | 114,000.0 |
| FBIO Fortress Biotech Inc | 19,946,000.0 | -28,984,000.0 |
| CDTX Cidara Therapeutics Inc | 17,583,000.0 | -5,611,000.0 |
| TELA TELA Bio Inc | 16,998,000.0 | -12,890,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股營收排名、龍頭是誰？
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例